Novato, Calif. -- Ultragenyx Pharmaceutical, a biotechnology firm focused on developing treatments for rare and ultra-rare genetic disorders, said on Monday it has relocated its corporate headquarters to a larger facility in the Bel Marin Keys area of Novato. The company said the move will accommodate future staff growth while allowing it to expand operations in the areas of clinical development, regulatory affairs, technical operations and administration. The company will continue to lease lab facilities at the Buck Institute in Novato, which currently houses its research staff.
http://www.ultragenyx.com
http://www.marketwatch.com/story/ultragenyx-relocates-company-headquarters-to-support-operational-expansion-2012-04-23
Listings
Notices
Recent Posts
- San Jose-Based Adobe Systems Acquires Behance
- Santa Clara-Based Coherent Acquires Germany's Lumera Laser
- Gangnam Style Becomes First Video to Hit 1 Billion Views on YouTube
- Redwood Shores-Based Oracle to Acquire Eloqua for $871 Million
- Palo Alto-Based Pluribus Networks Raises $23 Million in Third Round
- Foxconn Acquires $200 Million Stake in San Mateo-Based GoPro
- Palo Alto-Based LUMO BodyTech Raises $5 Million in First Round
- Palo Alto-Based Signifyd Lands $2 Million in Seed Funding
- San Francisco-Based FitStar Raises $1M for Health and Fitness Platform
- National Geographic Suspending New Posts on Instagram
Editor: Rich Scherr
For news tips and editorial issues,
contact editor Rich Scherr at
rich@techwiremedia.com
For advertising information, contract
Parul Nath at parul@techwiremedia.com
A Service of Tech Wire Media
Archives
- December 16, 2012 - December 22, 2012
- December 9, 2012 - December 15, 2012
- December 2, 2012 - December 8, 2012
- November 25, 2012 - December 1, 2012
- November 18, 2012 - November 24, 2012
- November 11, 2012 - November 17, 2012
- November 4, 2012 - November 10, 2012
- October 28, 2012 - November 3, 2012
- October 21, 2012 - October 27, 2012
- October 14, 2012 - October 20, 2012
